Position in ALLO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,105,809
+$5,583,219 QoQ
Shares Held
3,322,053
+80.4% QoQ
Ownership
0.962%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALLO Over Time
Shares Held
Position Value (USD)
Derivatives in ALLO
reported options exposure · as of Dec 31, 2020CallValue
$2,271,600
CallShares
90,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,468,729,571 across 342 Biotechnology names. ALLO ranks #127 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in ALLO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,105,809 | 3,322,053 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,522,590 | 1,841,307 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,203,632 | 3,390,026 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,698,078 | 1,502,724 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $374,999 | 256,849 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $722,405 | 258,002 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $418,523 | 179,624 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $900,570 | 201,470 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $6,160,034 | 1,919,014 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $394,341 | 124,398 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,042,537 | 209,766 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,954,800 | 1,002,996 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $20,600,529 | 3,275,124 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $15,081,973 | 1,396,479 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,856,340 | 776,872 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,203,686 | 571,206 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,313,092 | 155,033 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,875,611 | 228,623 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $13,178,093 | 505,295 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $9,988,664 | 282,965 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,271,600 | 90,000 | Call | Sole | 2021-02-16 | |
| 2020-12-31 | $10,739,165 | 425,482 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,573,632 | 68,248 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $8,871,404 | 207,179 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,001,179 | 51,501 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||